Identification of a new plant extract for androgenic alopecia treatment using a non-radioactive human hair dermal papilla cell-based assay

BMC Complementary and Alternative Medicine
Ruchy JainWanchai De-Eknamkul

Abstract

Androgenic alopecia (AGA) is a major type of human scalp hair loss, which is caused by two androgens: testosterone (T) and 5α-dihydrotestosterone (5α-DHT). Both androgens bind to the androgen receptor (AR) and induce androgen-sensitive genes within the human hair dermal papilla cells (HHDPCs), but 5α-DHT exhibits much higher binding affinity and potency than T does in inducing the involved androgen-sensitive genes. Changes in the induction of androgen-sensitive genes during AGA are caused by the over-production of 5α-DHT by the 5α-reductase (5α-R) enzyme; therefore, one possible method to treat AGA is to inhibit this enzymatic reaction. RT-PCR was used to identify the presence of the 5α-R and AR within HHDPCs. A newly developed AGA-relevant HHDPC-based assay combined with non-radioactive thin layer chromatography (TLC) detection was used for screening crude plant extracts for the identification of new 5α-R inhibitors. HHDPCs expressed both 5α-R type 1 isoform of the enzyme (5α-R1) and AR in all of the passages used in this study. Among the thirty tested extracts, Avicennia marina (AM) displayed the highest inhibitory activity at the final concentration of 10 μg/ml, as the production of 5α-DHT decreased by 52% (IC50 = 9.21 ± 0.3...Continue Reading

References

Apr 1, 1994·Clinical Endocrinology·V A Randall
Jul 1, 1993·The Journal of Investigative Dermatology·A G Messenger
Jan 1, 1996·Dermatology : International Journal for Clinical and Investigative Dermatology·W ChenC E Orfanos
Dec 3, 1999·The British Journal of Dermatology·E K BayneG Harris
Jun 27, 2001·Trends in Molecular Medicine·G Cotsarelis, S E Millar
Apr 5, 2002·Biochemical Pharmacology·Richard A HiipakkaShutsung Liao
Apr 20, 2002·Expert Review of Molecular Diagnostics·Michael P Murphy
Sep 6, 2002·Experimental Gerontology·Ralph M Trüeb
Oct 2, 2002·Journal of Dermatological Science·Seok-Seon RohYeo-Kyeong Yoon
Dec 13, 2002·The Journal of Steroid Biochemistry and Molecular Biology·Jean Pierre RaynaudPierre Marie Martin
Aug 5, 2003·The Journal of Investigative Dermatology. Symposium Proceedings·Vera H Price
Sep 2, 2003·Journal of Experimental Zoology. Part B, Molecular and Developmental Evolution·Vladimir A Botchkarev, Ralf Paus
May 3, 2005·Journal of Dermatological Science·Seok-Seon RhoMoon-Jeong Rang
Oct 11, 2005·Mayo Clinic Proceedings·Dow StoughKen Washenik
Jul 28, 2007·The Journal of Investigative Dermatology·Mi Hee KwackJung Chul Kim
Sep 16, 2008·Journal of Cosmetic Dermatology·Shweta PanditV K Dixit
Feb 10, 2009·Nature Clinical Practice. Urology·William P HarrisBruce Montgomery
Dec 20, 2011·Journal of Ethnopharmacology·Naphatsorn KumarChaiyavat Chaiyasut
May 31, 2014·Expert Opinion on Therapeutic Targets·Ruchy Jain, Wanchai De-Eknamkul

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
electrophoresis

Software Mentioned

Clone manager

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.